← Back to Clinical Trials
Recruiting NCT07468188

NCT07468188 Diabetes Body Project 2

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07468188
Status Recruiting
Phase —
Sponsor Joslin Diabetes Center
Condition Eating Disorders
Study Type INTERVENTIONAL
Enrollment 42 participants
Start Date 2025-01-24
Primary Completion 2027-02-28

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Body Project Type 2

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 42 participants in total. It began in 2025-01-24 with a primary completion date of 2027-02-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to test the feasibility and effectiveness of an eating disorder prevention program specifically targeted for women with type 2 diabetes (T2D) called the Diabetes Body Project 2 (DBP2). The Diabetes Body Project 2 (DBP2) will be adapted from the Diabetes Body Project, which is an eating disorder prevention program developed to improve satisfaction with body image and diabetes management for young women with type 1 diabetes (DBP). The study is looking to see if the DBP is effective in improving body image concerns, reducing disordered eating behaviors and improving glycemic control in women with T2D.

Eligibility Criteria

Inclusion Criteria: * 1.) Female sex 2) self-reported gender identity of "woman"; 3) age 18-40 years old; 4) diagnosed with T2D for at least 6 months; 5) experiencing at least one body image concern. Exclusion Criteria: * Recent hospitalization for eating disorder within the last 12 months * Eating disorder related diabetic ketoacidosis within the last 12 months * unwillingness to be video-recorded, * restricted English proficiency * developmental, cognitive, or psychiatric limitations that compromise participation in the intervention sessions and study.

Contact & Investigator

Central Contact

Christine Slyne

✉ christine.slyne@joslin.harvard.edu

📞 6173094683

Frequently Asked Questions

Who can join the NCT07468188 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07468188 currently recruiting?

Yes, NCT07468188 is actively recruiting participants. Contact the research team at christine.slyne@joslin.harvard.edu for enrollment information.

Where is the NCT07468188 trial being conducted?

This trial is being conducted at Boston, United States.

Who is sponsoring the NCT07468188 clinical trial?

NCT07468188 is sponsored by Joslin Diabetes Center. The trial plans to enroll 42 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology